Triose Phosphate Isomerase: Difference between revisions
Gregg Snider (talk | contribs) |
Gregg Snider (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{STRUCTURE_1tim | PDB=1tim | SCENE= }} | {{STRUCTURE_1tim | PDB=1tim | SCENE= }} | ||
| Line 20: | Line 19: | ||
=== Triose Phosphate Isomerase Deficiency == | === Triose Phosphate Isomerase Deficiency === | ||
Triose Phosphate Isomease Deficiency is a rare (less then 100 cases worldwide), autosomal recessive disorder first described in 1965.<Schneider, Arthur S.; William N. Valentine, Hattori M, H. L. Heins Jr (1965). "Hereditary Hemolytic Anemia with Triosephosphate Isomerase Deficiency". New England Journal of Medicine 272: 229–35> Symptoms include haemolytic anaemia, cardiomyopathy, an increased susceptibility to infections, severe neurological dysfunctions, and, often times, death in early childhood. | Triose Phosphate Isomease Deficiency is a rare (less then 100 cases worldwide), autosomal recessive disorder first described in 1965.<Schneider, Arthur S.; William N. Valentine, Hattori M, H. L. Heins Jr (1965). "Hereditary Hemolytic Anemia with Triosephosphate Isomerase Deficiency". New England Journal of Medicine 272: 229–35> Symptoms include haemolytic anaemia, cardiomyopathy, an increased susceptibility to infections, severe neurological dysfunctions, and, often times, death in early childhood. | ||
Revision as of 01:30, 19 March 2009
Triose Phosphate Isomerase (TPI or TIM) which catalyzes the reversible interconversion of the triose phosphate isomers dihydroxyacetone phosphate and D-glyceraldehyde-3-phosphate, an essential process in the glycolytic pathway.
MechanismMechanism
Acid Base CatalysisAcid Base Catalysis
Diagram .<ref name= "web.virginia.edu" [1]
Structure & Function
Disease
Triose Phosphate Isomerase Deficiency
Triose Phosphate Isomease Deficiency is a rare (less then 100 cases worldwide), autosomal recessive disorder first described in 1965.<Schneider, Arthur S.; William N. Valentine, Hattori M, H. L. Heins Jr (1965). "Hereditary Hemolytic Anemia with Triosephosphate Isomerase Deficiency". New England Journal of Medicine 272: 229–35> Symptoms include haemolytic anaemia, cardiomyopathy, an increased susceptibility to infections, severe neurological dysfunctions, and, often times, death in early childhood.